Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antimalarial drugs refer to drugs used to prevent or treat malaria. Malaria makes people sick and fatal through several different degrees of pathological mechanisms. The purpose of treatment is to prevent death or long-term diseases caused by malaria, reduce the incidence of acute diseases, and completely eliminate infections so that they will not relapse.
The report includes analysis of major segments of the global antimalarial market based on product type, application, and region. The report contains market research on different factors, such as market size, market share, industry competition and growth, and other quantitative information. Malaria is a malignant infectious disease with an extremely widespread epidemic and extremely high morbidity and mortality in the world. More than 500 million people are infected each year, and three million patients die. And more than half of the victims are children in Africa. The resistance of plasmodium falciparum resistance to artemisinin is a public health problem that urgently needs to be addressed, threatening the sustainability of the global malaria reduction effort. The delivery of malaria control products such as mosquito nets and insecticides has also hindered the development of the antimalarial market.
According to data from the World Health Organization's World Malaria Report 2019, among the population of the children of receiving antimalarial treatment, children who are treated in public hospitals are more likely to receive artemisinin-based combinations or combination medications slightly higher than formal private hospitals or the informal private sector, therefore, hospital pharmacies have the highest share of antimalarial drugs.
The main factors driving the growth of the antimalarial market include the rising prevalence of malaria in developing countries, which has led to an increase in the demand for antimalarial drugs. In addition, the government's measures to increase health awareness, timely diagnosis and treatment to prevent the development of malaria from severe to death, and research on new antimalarial drugs are some other factors that promote market growth.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Antimalarial Drug market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Antimalarial Drug market. Detailed analysis of key players, along with key growth strategies adopted by Antimalarial Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Novartis AG
Merck KGaA
F Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Mayne Pharma Group Limited
Sanofi SA
King Pharmaceuticals, Inc
Alvizia Health Care
Bayer
By Type:
Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale
By End-User:
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Antimalarial Drug Market
-
1.3 Market Segment by Type
-
1.3.1 USA Antimalarial Drug Market Size and Growth Rate of Plasmodium Falciparum from 2016 to 2027
-
1.3.2 USA Antimalarial Drug Market Size and Growth Rate of Plasmodium Vivax from 2016 to 2027
-
1.3.3 USA Antimalarial Drug Market Size and Growth Rate of Plasmodium Malariae from 2016 to 2027
-
1.3.4 USA Antimalarial Drug Market Size and Growth Rate of Plasmodium Ovale from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Antimalarial Drug Market Size and Growth Rate of Hospital Pharmacy from 2016 to 2027
-
1.4.2 USA Antimalarial Drug Market Size and Growth Rate of Retail Pharmacy from 2016 to 2027
-
1.4.3 USA Antimalarial Drug Market Size and Growth Rate of E-Commerce from 2016 to 2027
-
1.4.4 USA Antimalarial Drug Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Antimalarial Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Antimalarial Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Antimalarial Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Antimalarial Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Antimalarial Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Antimalarial Drug by Major Types
-
3.4.1 Market Size and Growth Rate of Plasmodium Falciparum
-
3.4.2 Market Size and Growth Rate of Plasmodium Vivax
-
3.4.3 Market Size and Growth Rate of Plasmodium Malariae
-
3.4.4 Market Size and Growth Rate of Plasmodium Ovale
4 Segmentation of Antimalarial Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Antimalarial Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Antimalarial Drug in Hospital Pharmacy
-
4.4.2 Market Size and Growth Rate of Antimalarial Drug in Retail Pharmacy
-
4.4.3 Market Size and Growth Rate of Antimalarial Drug in E-Commerce
-
4.4.4 Market Size and Growth Rate of Antimalarial Drug in Others
5 Market Analysis by Regions
-
5.1 USA Antimalarial Drug Production Analysis by Regions
-
5.2 USA Antimalarial Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Antimalarial Drug Landscape Analysis
-
6.1 West USA Antimalarial Drug Landscape Analysis by Major Types
-
6.2 West USA Antimalarial Drug Landscape Analysis by Major End-Users
7 South USA Antimalarial Drug Landscape Analysis
-
7.1 South USA Antimalarial Drug Landscape Analysis by Major Types
-
7.2 South USA Antimalarial Drug Landscape Analysis by Major End-Users
8 Middle West USA Antimalarial Drug Landscape Analysis
-
8.1 Middle West USA Antimalarial Drug Landscape Analysis by Major Types
-
8.2 Middle West USA Antimalarial Drug Landscape Analysis by Major End-Users
9 Northeast USA Antimalarial Drug Landscape Analysis
-
9.1 Northeast USA Antimalarial Drug Landscape Analysis by Major Types
-
9.2 Northeast USA Antimalarial Drug Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Novartis AG
-
10.1.1 Novartis AG Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Merck KGaA
-
10.2.1 Merck KGaA Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 F Hoffmann-La Roche Ltd
-
10.3.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 GlaxoSmithKline plc
-
10.4.1 GlaxoSmithKline plc Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Mayne Pharma Group Limited
-
10.5.1 Mayne Pharma Group Limited Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Sanofi SA
-
10.6.1 Sanofi SA Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 King Pharmaceuticals, Inc
-
10.7.1 King Pharmaceuticals, Inc Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Alvizia Health Care
-
10.8.1 Alvizia Health Care Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Bayer
-
10.9.1 Bayer Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Antimalarial Drug Market Size and Growth Rate of Plasmodium Falciparum from 2016 to 2027
-
Figure USA Antimalarial Drug Market Size and Growth Rate of Plasmodium Vivax from 2016 to 2027
-
Figure USA Antimalarial Drug Market Size and Growth Rate of Plasmodium Malariae from 2016 to 2027
-
Figure USA Antimalarial Drug Market Size and Growth Rate of Plasmodium Ovale from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Antimalarial Drug Market Size and Growth Rate of Hospital Pharmacy from 2016 to 2027
-
Figure USA Antimalarial Drug Market Size and Growth Rate of Retail Pharmacy from 2016 to 2027
-
Figure USA Antimalarial Drug Market Size and Growth Rate of E-Commerce from 2016 to 2027
-
Figure USA Antimalarial Drug Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Antimalarial Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Antimalarial Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Antimalarial Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Antimalarial Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Antimalarial Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Antimalarial Drug
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Antimalarial Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Antimalarial Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Plasmodium Falciparum
-
Figure Market Size and Growth Rate of Plasmodium Vivax
-
Figure Market Size and Growth Rate of Plasmodium Malariae
-
Figure Market Size and Growth Rate of Plasmodium Ovale
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Antimalarial Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Antimalarial Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital Pharmacy
-
Figure Market Size and Growth Rate of Retail Pharmacy
-
Figure Market Size and Growth Rate of E-Commerce
-
Figure Market Size and Growth Rate of Others
-
Table USA Antimalarial Drug Production by Regions
-
Table USA Antimalarial Drug Production Share by Regions
-
Figure USA Antimalarial Drug Production Share by Regions in 2016
-
Figure USA Antimalarial Drug Production Share by Regions in 2021
-
Figure USA Antimalarial Drug Production Share by Regions in 2027
-
Table USA Antimalarial Drug Consumption by Regions
-
Table USA Antimalarial Drug Consumption Share by Regions
-
Figure USA Antimalarial Drug Consumption Share by Regions in 2016
-
Figure USA Antimalarial Drug Consumption Share by Regions in 2021
-
Figure USA Antimalarial Drug Consumption Share by Regions in 2027
-
Table West USA Antimalarial Drug Consumption by Types from 2016 to 2027
-
Table West USA Antimalarial Drug Consumption Share by Types from 2016 to 2027
-
Figure West USA Antimalarial Drug Consumption Share by Types in 2016
-
Figure West USA Antimalarial Drug Consumption Share by Types in 2021
-
Figure West USA Antimalarial Drug Consumption Share by Types in 2027
-
Table West USA Antimalarial Drug Consumption by End-Users from 2016 to 2027
-
Table West USA Antimalarial Drug Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Antimalarial Drug Consumption Share by End-Users in 2016
-
Figure West USA Antimalarial Drug Consumption Share by End-Users in 2021
-
Figure West USA Antimalarial Drug Consumption Share by End-Users in 2027
-
Table South USA Antimalarial Drug Consumption by Types from 2016 to 2027
-
Table South USA Antimalarial Drug Consumption Share by Types from 2016 to 2027
-
Figure South USA Antimalarial Drug Consumption Share by Types in 2016
-
Figure South USA Antimalarial Drug Consumption Share by Types in 2021
-
Figure South USA Antimalarial Drug Consumption Share by Types in 2027
-
Table South USA Antimalarial Drug Consumption by End-Users from 2016 to 2027
-
Table South USA Antimalarial Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Antimalarial Drug Consumption Share by End-Users in 2016
-
Figure South USA Antimalarial Drug Consumption Share by End-Users in 2021
-
Figure South USA Antimalarial Drug Consumption Share by End-Users in 2027
-
Table Middle West USA Antimalarial Drug Consumption by Types from 2016 to 2027
-
Table Middle West USA Antimalarial Drug Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Antimalarial Drug Consumption Share by Types in 2016
-
Figure Middle West USA Antimalarial Drug Consumption Share by Types in 2021
-
Figure Middle West USA Antimalarial Drug Consumption Share by Types in 2027
-
Table Middle West USA Antimalarial Drug Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Antimalarial Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Antimalarial Drug Consumption Share by End-Users in 2016
-
Figure Middle West USA Antimalarial Drug Consumption Share by End-Users in 2021
-
Figure Middle West USA Antimalarial Drug Consumption Share by End-Users in 2027
-
Table Northeast USA Antimalarial Drug Consumption by Types from 2016 to 2027
-
Table Northeast USA Antimalarial Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Antimalarial Drug Consumption Share by Types in 2016
-
Figure Northeast USA Antimalarial Drug Consumption Share by Types in 2021
-
Figure Northeast USA Antimalarial Drug Consumption Share by Types in 2027
-
Table Northeast USA Antimalarial Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Antimalarial Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Antimalarial Drug Consumption Share by End-Users in 2016
-
Figure Northeast USA Antimalarial Drug Consumption Share by End-Users in 2021
-
Figure Northeast USA Antimalarial Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Novartis AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG
-
Figure Sales and Growth Rate Analysis of Novartis AG
-
Figure Revenue and Market Share Analysis of Novartis AG
-
Table Product and Service Introduction of Novartis AG
-
Table Company Profile and Development Status of Merck KGaA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA
-
Figure Sales and Growth Rate Analysis of Merck KGaA
-
Figure Revenue and Market Share Analysis of Merck KGaA
-
Table Product and Service Introduction of Merck KGaA
-
Table Company Profile and Development Status of F Hoffmann-La Roche Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd
-
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd
-
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd
-
Table Product and Service Introduction of F Hoffmann-La Roche Ltd
-
Table Company Profile and Development Status of GlaxoSmithKline plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline plc
-
Table Product and Service Introduction of GlaxoSmithKline plc
-
Table Company Profile and Development Status of Mayne Pharma Group Limited
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mayne Pharma Group Limited
-
Figure Sales and Growth Rate Analysis of Mayne Pharma Group Limited
-
Figure Revenue and Market Share Analysis of Mayne Pharma Group Limited
-
Table Product and Service Introduction of Mayne Pharma Group Limited
-
Table Company Profile and Development Status of Sanofi SA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi SA
-
Figure Sales and Growth Rate Analysis of Sanofi SA
-
Figure Revenue and Market Share Analysis of Sanofi SA
-
Table Product and Service Introduction of Sanofi SA
-
Table Company Profile and Development Status of King Pharmaceuticals, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of King Pharmaceuticals, Inc
-
Figure Sales and Growth Rate Analysis of King Pharmaceuticals, Inc
-
Figure Revenue and Market Share Analysis of King Pharmaceuticals, Inc
-
Table Product and Service Introduction of King Pharmaceuticals, Inc
-
Table Company Profile and Development Status of Alvizia Health Care
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alvizia Health Care
-
Figure Sales and Growth Rate Analysis of Alvizia Health Care
-
Figure Revenue and Market Share Analysis of Alvizia Health Care
-
Table Product and Service Introduction of Alvizia Health Care
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
